GSK warns of declining vaccine sales in 2024 due to lower demand for respiratory syncytial virus vaccines
GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, sending its shares down 4 per cent in early trading.
ENTRADAS POPULARES
Thousands left without power in Washington State
noviembre 21, 2024
Eight times as many children will face extreme heatwaves in 2050
noviembre 21, 2024
Elton John’s Tammy Faye to close on Broadway
noviembre 21, 2024
TRANSMISIÓN EN VIVO